UA99150C2 - Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств - Google Patents

Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств

Info

Publication number
UA99150C2
UA99150C2 UAA201005122A UAA201005122A UA99150C2 UA 99150 C2 UA99150 C2 UA 99150C2 UA A201005122 A UAA201005122 A UA A201005122A UA A201005122 A UAA201005122 A UA A201005122A UA 99150 C2 UA99150 C2 UA 99150C2
Authority
UA
Ukraine
Prior art keywords
traumatic stress
stress disorders
treating post
tetrahydroquinoline derivatives
alkyl
Prior art date
Application number
UAA201005122A
Other languages
English (en)
Ukrainian (uk)
Inventor
Франсуа Жанк
Original Assignee
Актелион Фармасьютикалс Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40467356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA99150(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Актелион Фармасьютикалс Лтд filed Critical Актелион Фармасьютикалс Лтд
Publication of UA99150C2 publication Critical patent/UA99150C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Данное изобретение относится к применению производных тетрагидрохинолина формулы IIa,гдеRи Rкаждый независимо означает С-Салкоксигруппу,Rозначает арил(С-С)алкил или гетероарил(С-С)алкил, иRозначает С-Салкил,или фармацевтически приемлемым солям указанных соединений для получения лекарственного средства, предназначенного для профилактики или лечения посттравматических стрессовых расстройств.
UAA201005122A 2007-10-10 2008-10-09 Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств UA99150C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2007054130 2007-10-10

Publications (1)

Publication Number Publication Date
UA99150C2 true UA99150C2 (ru) 2012-07-25

Family

ID=40467356

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201005122A UA99150C2 (ru) 2007-10-10 2008-10-09 Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств

Country Status (28)

Country Link
US (1) US9532985B2 (ru)
EP (1) EP2207550B1 (ru)
JP (1) JP5883222B2 (ru)
KR (1) KR101733247B1 (ru)
CN (1) CN101820878B (ru)
AR (1) AR068768A1 (ru)
AU (1) AU2008309194B2 (ru)
BR (1) BRPI0818617A2 (ru)
CA (1) CA2699504C (ru)
CY (1) CY1114799T1 (ru)
DK (1) DK2207550T3 (ru)
EA (1) EA017443B1 (ru)
ES (1) ES2444418T3 (ru)
HK (1) HK1145440A1 (ru)
HR (1) HRP20140214T1 (ru)
IL (1) IL204838A (ru)
MA (1) MA31800B1 (ru)
MX (1) MX2010003711A (ru)
MY (1) MY153044A (ru)
NZ (1) NZ585086A (ru)
PE (1) PE20091010A1 (ru)
PL (1) PL2207550T3 (ru)
PT (1) PT2207550E (ru)
SI (1) SI2207550T1 (ru)
TW (1) TWI428129B (ru)
UA (1) UA99150C2 (ru)
WO (1) WO2009047723A2 (ru)
ZA (1) ZA201003251B (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513466A (ja) 2006-12-22 2010-04-30 アクテリオン ファーマシューティカルズ リミテッド ５，６，７，８−テトラヒドロ−イミダゾ［１，５−ａ］ピラジン誘導体
CN102076694A (zh) 2008-06-25 2011-05-25 埃科特莱茵药品有限公司 5，6，7，8-四氢-咪唑并[1，5-a]吡嗪化合物
EP2402322A1 (en) 2010-07-02 2012-01-04 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisoquinoline derivative and its use as orexin receptor antagonist
JP5744203B2 (ja) 2010-08-24 2015-07-08 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ オレキシン受容体拮抗薬としてのプロリンスルフォンアミド誘導体
PT2626350E (pt) 2010-09-22 2015-08-03 Eisai R&D Man Co Ltd Composto de ciclopropano
US9242970B2 (en) 2010-11-10 2016-01-26 Actelion Pharmaceuticals Ltd. Lactam derivatives useful as orexin receptor antagonists
WO2012085852A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
ES2541531T3 (es) 2011-02-18 2015-07-21 Actelion Pharmaceuticals Ltd. Nuevos derivados de pirazol e imidazol útiles como antagonistas de orexina
WO2012114252A1 (en) 2011-02-21 2012-08-30 Actelion Pharmaceuticals Ltd Novel indole and pyrrolopyridine amides
WO2013050938A1 (en) 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
AR088692A1 (es) 2011-11-08 2014-06-25 Actelion Pharmaceuticals Ltd Derivados de 2-(1,2,3-triazol-2-il)benzamina y 3-(1,2,3-triazol-2-il)picolinamida
DK2855453T3 (en) 2012-06-04 2017-02-06 Actelion Pharmaceuticals Ltd Benzimidazol-proline derivatives
BR112015007516A2 (pt) 2012-10-10 2017-07-04 Actelion Pharmaceuticals Ltd antagonistas do receptor de orexina que são derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)- pirrolidin-1-il]-metanona
EP2970241A1 (en) 2013-03-12 2016-01-20 Actelion Pharmaceuticals Ltd. Azetidine amide derivatives as orexin receptor antagonists
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
MX364208B (es) 2013-12-03 2019-04-16 Idorsia Pharmaceuticals Ltd Forma cristalina de (s)-(2-(6-cloro)-7-metil-1h-benzo[d]imidazol-2 -il)-2-metilpirrolidin-1-il) (5-metoxi-2-(2h-1,2,3-triazol-2-il)fe nil) metanona y su uso como antagonistas de receptor de orexina.
KR102330133B1 (ko) 2013-12-04 2021-11-23 이도르시아 파마슈티컬스 리미티드 벤즈이미다졸-프롤린 유도체의 용도
CN107810006B (zh) 2014-10-23 2021-03-30 卫材R&D管理有限公司 用于治疗失眠的组合物
CN115710250A (zh) * 2017-08-01 2023-02-24 博健制药有限责任公司 一种食欲素受体拮抗剂的晶型及其制备方法和用途
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020007977A1 (en) 2018-07-06 2020-01-09 Idorsia Pharmaceuticals Ltd 7-trifluoromethyl-[1,4]diazepan derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
WO2023218023A1 (en) 2022-05-13 2023-11-16 Idorsia Pharmaceuticals Ltd Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02008797A (es) 2000-03-14 2005-09-08 Actelion Pharmaceuticals Ltd Derivados de 1,2,3,4-tetrahidroisoquinolina.
CA2518945A1 (en) * 2003-03-26 2004-10-07 Actelion Pharmaceuticals Ltd. Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
CA2557163C (en) 2004-03-01 2011-08-16 Actelion Pharmaceuticals Ltd Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
US7501395B2 (en) 2005-04-25 2009-03-10 Eisai R & D Management Co., Ltd. Method of screening for antianxiety drugs
BRPI0708913A2 (pt) 2006-03-15 2011-06-14 Actelion Pharmaceuticals Ltd uso de compostos derivados de tetraidroisoquinolina para aumentar a funÇço da memària
EP2402322A1 (en) 2010-07-02 2012-01-04 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisoquinoline derivative and its use as orexin receptor antagonist

Also Published As

Publication number Publication date
PT2207550E (pt) 2014-02-07
SI2207550T1 (sl) 2014-03-31
AU2008309194B2 (en) 2013-10-03
ZA201003251B (en) 2011-07-27
HRP20140214T1 (hr) 2014-04-11
MY153044A (en) 2014-12-31
MA31800B1 (fr) 2010-10-01
JP2011500550A (ja) 2011-01-06
BRPI0818617A2 (pt) 2015-04-07
MX2010003711A (es) 2010-04-30
CN101820878B (zh) 2012-02-01
IL204838A0 (en) 2010-11-30
AR068768A1 (es) 2009-12-02
NZ585086A (en) 2012-03-30
WO2009047723A2 (en) 2009-04-16
CN101820878A (zh) 2010-09-01
IL204838A (en) 2014-09-30
TW200932231A (en) 2009-08-01
CA2699504A1 (en) 2009-04-16
HK1145440A1 (en) 2011-04-21
AU2008309194A1 (en) 2009-04-16
KR20100065203A (ko) 2010-06-15
US20100234420A1 (en) 2010-09-16
EA201000557A1 (ru) 2010-10-29
PE20091010A1 (es) 2009-08-08
US9532985B2 (en) 2017-01-03
EA017443B1 (ru) 2012-12-28
WO2009047723A3 (en) 2009-05-28
ES2444418T3 (es) 2014-02-25
JP5883222B2 (ja) 2016-03-09
KR101733247B1 (ko) 2017-05-08
CY1114799T1 (el) 2016-12-14
CA2699504C (en) 2015-11-24
EP2207550A2 (en) 2010-07-21
TWI428129B (zh) 2014-03-01
DK2207550T3 (da) 2014-01-27
EP2207550B1 (en) 2013-12-11
PL2207550T3 (pl) 2014-05-30

Similar Documents

Publication Publication Date Title
UA99150C2 (ru) Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств
GEP201606532B (en) Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
MX2014015158A (es) Derivados de piridinona y piridazinona.
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
NZ601483A (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MY184306A (en) Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
IN2014DN09434A (ru)
MD4602B1 (ru) Ингибиторы вируса гепатита С
WO2012142093A3 (en) 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GEP20207129B (en) Inhibitors of influenza viruses replication
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
TW201000473A (en) Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
UA104489C2 (ru) Соединения для лечения дислипидемии и родственных болезней
MX2010013682A (es) Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos.
PH12015501560A1 (en) Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases
NZ605841A (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
TW200738651A (en) Cyclohexyl sulfonamide derivatives
UA103500C2 (ru) Сульфоксиминзамещенные анилинопиримидиновые производные как cdk-ингибиторы, их получение и применение как лекарственных средств
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
MX2012013879A (es) Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas.
WO2010121675A3 (en) Thiazolyl-benzimidazoles
MX2014003701A (es) Compuestos para el tratamiento y profilaxis de enfermedad por el virus sincitial respiratorio.
GEP20156244B (en) New tertiary 8-hydroxyquinoline-7- carboxamide derivatives and usage thereof
IL207250A0 (en) Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas
MY167075A (en) Benzodioxole derivative and preparation method and use thereof